Dnb Asset Management as

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
738
Total Value
21693954664
Accession Number
0000912282-25-000535
Form Type
13F-HR
Manager Name
Dnb Asset Management as
Data Enrichment
98% identified
720 identified18 unidentified

Holdings

738 positions
Manager:
Search and click to pin securities to the top
Page 35 of 37
Kanzhun Ltd
Shares:
17544(+0.0%)
Value:
$336.3M(+38.9%)
Alkermes plc.
Shares:
9928(-24.6%)
Value:
$327.8M(-13.5%)
CLEANSPARK, INC.
Shares:
48492
Value:
$325.9M
Immunocore Holdings plc
Shares:
10853(+5.4%)
Value:
$322.0M(+6.0%)
Krystal Biotech, Inc.
Shares:
1779(+15.7%)
Value:
$320.8M(+33.2%)
XPO, Inc.
Shares:
2968
Value:
$319.3M
AMBARELLA INC
Shares:
6259
Value:
$315.0M
IOVANCE BIOTHERAPEUTICS, INC.
Shares:
91580(+124.6%)
Value:
$305.0M(+1.1%)
NUSCALE POWER Corp
Shares:
20659
Value:
$292.5M
AMICUS THERAPEUTICS, INC.
Shares:
35519(+9.5%)
Value:
$289.8M(-5.2%)
ANAVEX LIFE SCIENCES CORP.
Shares:
33261
Value:
$285.4M
IREN Ltd
Shares:
46855
Value:
$285.3M
TG THERAPEUTICS, INC.
Shares:
7121
Value:
$280.8M
Syndax Pharmaceuticals Inc
Shares:
22378(-2.5%)
Value:
$274.9M(-9.4%)
uniQure N.V.
Shares:
25320(+14.9%)
Value:
$268.4M(-31.0%)
CENTRUS ENERGY CORP
Shares:
4312
Value:
$268.3M
Butterfly Network, Inc.
Shares:
114966
Value:
$262.1M
Leidos Holdings, Inc.
Shares:
1926
Value:
$259.9M
ACADIA PHARMACEUTICALS INC
Shares:
15611(+9.9%)
Value:
$259.3M(-0.5%)
Crinetics Pharmaceuticals, Inc.
Shares:
7431
Value:
$249.2M